Australia New Zealand
Therapeutic Products
Authority

Information last updated: 12 July 2006
URL: http://www.anztpa.org/consult/
   dsebworkflow.htm

• Home
• About the project
• Contact us
• Media centre
• A-Z guide
• Glossary
• Consultations
• Questions & answers
• Fact sheets
• ANZTPA Orders

---

• Advertising scheme
• Manufacturing
• Medicines labelling
• Prescription medicines
• Complementary medicines
• OTC medicines
• Medical devices
• Other links & information

---

• Copyright, security, disclaimer, privacy

Home | Prescription medicines | Workflow practices within DSEB
Print this page

TGA releases final report into the review of workflow practices within the Drug Safety and Evaluation Branch (DSEB)

17 July 2006

In 2005 the Therapeutic Goods Administration (TGA) engaged the services of mpconsulting to provide advice on the most appropriate means for improving workflow practices within the Drug Safety and Evaluation Branch (DSEB). A review was completed which examined the workflow practices of DSEB with a view to aligning them with best practice and international standards.

Consultations with affected stakeholders were undertaken in late 2005 in both New Zealand and Australia. New Zealand stakeholders were consulted since it is anticipated that improvements implemented as a result of this review will flow through into the development of business practices for the Australia New Zealand Therapeutic Products Authority (ANZTPA).

The final report of this review is now available on the TGA website. The report recommends changes to current practices including changes to the way that applications to register or vary registrations of prescription medicines are processed. The report also makes recommendations to enhance the transparency of TGA operations including the publication of previously unpublished information.

URL: http://www.anztpa.org/consult/dsebworkflow.htm